1981
DOI: 10.1002/j.1552-4604.1981.tb02626.x
|View full text |Cite
|
Sign up to set email alerts
|

Topical Δ9‐Tetrahydrocannabinol and Aqueous Dynamics in Glaucoma

Abstract: : Systemic Δ9‐tetrahydrocannabinol (THC), administered either by smoking marihuana or as synthetic THC in soft gelatin capsules, lowers ocular tension in various glaucomas, but at the expense of significant decreases in systolic blood pressure. Topical THC in light mineral oil vehicles, though effective in laboratory animals, was not shown effective in 0.05 and 0.1% topical solutions when administered to six subjects with primary open‐angle glaucoma in a randomized, balanced, double‐masked protocol. Light min… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
34
1
1

Year Published

1983
1983
2016
2016

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 62 publications
(36 citation statements)
references
References 4 publications
0
34
1
1
Order By: Relevance
“…However, in clinical studies, the efficacy of topical administration was not clearly established [22] and sometimes was absent [17,23]. It should be emphasized that in these studies, A9-THC was dissolved in a mineral oil vehicle.…”
Section: Discussionmentioning
confidence: 99%
“…However, in clinical studies, the efficacy of topical administration was not clearly established [22] and sometimes was absent [17,23]. It should be emphasized that in these studies, A9-THC was dissolved in a mineral oil vehicle.…”
Section: Discussionmentioning
confidence: 99%
“…[242][243][244] Marijuana smoking was shown to reduce IOP as early as 1971; the effect was later confirmed. [245][246][247][248] The peak effect of THC on the central nervous system coincided well with the reduction in intraocular pressure induced by the drug; However, hypotonia outlasted euphoria. The results indicate that THC may have value as a hypotonizing ocular drug.…”
Section: Asthma Cardiovascular Disorders Glaucomamentioning
confidence: 70%
“…Treatment twice daily for 60 days gave a maximum hypotensive effect for 0.1% A -THC without tachyphylaxis in rabbits (159). Topical A9-THC (0.1% and 1%) in normal dogs gave equipotent ocular pressure decreases, attributed to reduction in AH formation (160). However, another study did not show significant IOP reduction in rabbits given doses of up to 1% A -THC using several different vehicles (11).…”
Section: Cannabinoidsmentioning
confidence: 94%